Sana Biotechnology, Inc. (SANA) Tops Q3 EPS by 2c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
• Ascend Wellness Holdings, Inc. (AAWH) Tops Q2 EPS by 3c
• Stem wins deal to add 160 MWh of battery storage to Hungary solar plants